VivoSeq
Other

Colorectal Surgery

2

Pipeline Programs

7

Active Trials

4

Companies Involved

Colorectal Surgery is an early-stage landscape with 2 programs across 4 companies. The most active players are Hikma Pharmaceuticals LLC, Astellas, Colospan Ltd.. 2 therapies are approved.

Pipeline Metrics

Competitive Density

28/100

Pipeline Velocity

15/100

Mech. Concentration

100/100

Completion Rate

86/100

Attrition Rate

10/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs

Trial Status

59

clinical trials

Completed38 · 64%
Unknown status8 · 14%
Recruiting4 · 7%
Terminated4 · 7%
Not yet recruiting3 · 5%
Withdrawn2 · 3%

Trial Activity

59 trials

Inflammatory Markers After COloRectal Surgery)
Completed··N/A·NCT01510314·552 enrolled
Evaluation of Preoperative N1539 in Colorectal Surgery
Completed·BBaudax Bio·Phase 3·NCT03323385·57 enrolled
Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)